SCHEMBL14083047

SCHEMBL14083047

O=C(Nc1cccc(Cl)c1Cl)c1ccc(-c2ncccc2Cl)cn1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.51
▸ KMT2A Q03164 4/20 0.51
▸ MAPT P10636 2/20 0.51
▸ RAB9A P51151 2/20 0.51
▸ NPC1 O15118 1/20 0.51
▸ LMNA P02545 1/20 0.51
▸ HPGD P15428 1/20 0.51
▸ SMN1; SMN2 Q16637 1/20 0.51
▸ GAA P10253 1/20 0.51
▸ ALDH1A1 P00352 2/20 0.48
▸ KDM4E B2RXH2 1/20 0.47
▸ CYP1A2 P05177 1/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ CYP2C9 P11712 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ SCN5A Q14524 2/20 0.46
▸ SCN9A Q15858 2/20 0.46
▸ TRPV1 Q8NER1 3/20 0.46
▸ P4HTM Q9NXG6 1/20 0.45
▸ MCL1 Q07820 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14083924 0.90 MCL1 (0.57) MEN1KMT2AMAPTRAB9ANPC1
SCHEMBL14083483 0.86 MEN1 (0.67) MEN1KMT2AMAPTRAB9ANPC1
SCHEMBL14108041 0.85 HDAC1 (0.59) P4HTMMCL1KDR
SCHEMBL14083046 0.82 KDM4E (0.51) MEN1KMT2AMAPTRAB9ANPC1
SCHEMBL14083918 0.82 KMT2A (0.61) MEN1KMT2AMAPTRAB9ANPC1
SCHEMBL14083915 0.82 HDAC1 (0.53) MEN1KMT2ARAB9ANPC1HPGD
SCHEMBL14083912 0.82 TRPV1 (0.56) RAB9ANPC1ALDH1A1KDM4ECYP2C9
SCHEMBL14083940 0.81 HIF1A (0.51) CYP1A2CYP2C19SCN5ASCN9ATRPV1
SCHEMBL14083050 0.81 KMT2A (0.50) MEN1KMT2ARAB9ANPC1LMNA
SCHEMBL14083943 0.81 TRPV1 (0.58) MEN1KMT2ASMN1; SMN2TRPV1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof TRPV1, TRPA1, TRPV2 MEN1 4218/4885KMT2A 4272/4885MAPT 2822/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback